Temporary Stool-Diverting device aims to prevent dangerous leaks after colon surgery

NCT ID NCT03423485

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a temporary device called CG-100 that is placed inside the bowel after colorectal surgery to divert stool away from the surgical connection (anastomosis). The goal is to see if the device can create a leak-proof seal and reduce the risk of anastomotic leakage, a serious complication. About 30 adults scheduled for elective colorectal surgery will receive the device during their operation and be followed for about 10 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CG-100 Intraluminal Bypass Device
What this could lead to
If successful, this device could reduce the risk of dangerous leaks at the surgical connection after colorectal surgery, potentially improving recovery and reducing complications.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to all patients. The device may fail to seal properly or cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHUV, University Hospital Vaudois

    Lausanne, Switzerland

  • Carmel Medical Center

    Haifa, Israel

  • Hospital Beaujon

    Paris, Clichy, 92110, France

  • Soroka Medical Center

    Beersheba, 85025, Israel

  • University Hospital of Hamburg

    Hamburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.